Where do Cogent Biosciences, Inc.'s ratios come from?

Every ratio is computed from Cogent Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-73.7%+25.8pp	-99.5%-24.6pp	-74.9%-15.2pp	-59.7%-27.5pp
Return on invested capital	-129.2%+9.1pp	-138.3%-22.3pp	-116%—	——
Liquidity
Current ratio	14.2×+8.9×	5.3×-1.8×	7.1×-2.8×	9.9×-3.2×
Leverage
Debt-to-equity	0×0.0×	0.1×0.0×	0.1×0.0×	0.1×+0.1×
Per Share
Book value per share	$4.94+100%	$2.47-23.8%	$3.24-25.7%	$4.35-21.3%
Valuation
Market capitalization	$5.45B+533%	$861.6M+70.1%	$506.41M-37.3%	$807.97M+136%
Price / book	8.6×+5.2×	3.4×+1.4×	2×-1.2×	3.2×+1.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Cogent Biosciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Cogent Biosciences, Inc.'s ratios come from?: Every ratio is computed from Cogent Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.